HP Government Seeks API Investment as Bulk Drug Park Enters Tender Phase
With tenders already floated for key infrastructure components, the state is inviting pharmaceutical companies—particularly those involved in active pharmaceutical ingredients (APIs) and key starting materials (KSMs)—to express interest. Plot allotments, coupled with attractive incentive packages, are expected to commence shortly.
Manufacturing | 14/07/2025 | By Darshana | 258
BDMAI to Launch Exclusive E-Marketing Portal for Indian Bulk Drug Industry
Aimed particularly at supporting small and medium enterprises (SMEs), the portal will enable bulk drug manufacturers to showcase their products and services digitally, thereby expanding their market reach through digitalisation.
Manufacturing | 14/07/2025 | By Darshana | 125
Sentio BioSciences to Invest USD 10.6 Million in Missouri Manufacturing Expansion
The project will also introduce new infrastructure to support the company’s growing contract development and manufacturing organisation (CDMO) services. Construction is scheduled for completion in 2026.
Manufacturing | 11/07/2025 | By Darshana
Emcure's Sanand Manufacturing Facility Clears US FDA Inspection With Zero Observations
The PAI, held between June 30 and July 8, 2025, is a critical regulatory step for pharmaceutical companies seeking approval to launch new products in the US. It assesses a manufacturing site’s adherence to Good Manufacturing Practices (GMP) and overall readiness to support a pending New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Manufacturing | 10/07/2025 | By Darshana | 145
Deadline for Submitting PLI Applications For KSM, API Manufacturing Extended Again
The Department of Pharmaceuticals (DoP) has once again extended the deadline for submitting applications for the eligible products under the "Production Linked Incentive Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India.”
Manufacturing | 09/07/2025 | By Dineshwori | 258
Esaote Showcases 'Vet-MR Grande ELITE' ECVS 2025
Esaote presents the new Vet-MR Grande ELITE, the next generation of veterinary MRI at ECVS 2025.
Manufacturing | 04/07/2025 | By Manvi
Biological E Partners with China's Recbio to Manufacture HPV9 Vaccine
Biological E. Ltd (BE) has entered into a licensing cooperation agreement with Jiangsu Recbio Technology Co Ltd. to produce and commercialise the Chinese company’s recombinant 9-valent Human Papillomavirus (HPV9) vaccine, REC603, in India and select global markets.
Manufacturing | 02/07/2025 | By Manvi | 102
AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country
According to World Health Organisation, more than four lakh cases of endometrial cancer were diagnosed in 2022 with >17,000 cases newly detected in India. The incidence of endometrial cancer is projected to increase by >20% globally and in India.<br />
Manufacturing | 02/07/2025 | By Darshana
Planned as PPP-driven (public-private partnership) healthcare ecosystem, these MediCities will plug India’s healthcare infrastructure gap. Simultaneously, they will support employment and medical research opportunities to position India as a global destination for tertiary and affordable care.
Manufacturing | 25/06/2025 | By Darshana | 144
Ocutrx Debuts HemoLucence Surgical Breakthrough
Ocutrx Technologies Inc. through its R&D division Genius Labs, unveiled a major surgical innovation: the ability to render blood translucent in real time during surgery.
Manufacturing | 25/06/2025 | By Manvi | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy